# Therapeutic Value of Sirolimus in Refractory Adult-Onset Still's Disease

> **NCT07151157** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Ruijin Hospital** · enrollment: 3 (estimated)

## Conditions studied

- Adult-Onset Still's Disease

## Interventions

- **DRUG:** add-on sirolimus therapy

## Key facts

- **NCT ID:** NCT07151157
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-08-30
- **Primary completion:** 2026-04-01
- **Final completion:** 2026-08-30
- **Target enrollment:** 3 (ESTIMATED)
- **Last updated:** 2025-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07151157

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07151157, "Therapeutic Value of Sirolimus in Refractory Adult-Onset Still's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07151157. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*